Left atrial (LA) volume is a marker of cardiac remodeling and prognosis in heart failure (HF) with reduced ejection fraction (EF), but LA function is rarely measured or characterized. We investigated determinants and prognostic impact of LA reservoir function in patients with HF with reduced EF.
L
eft atrial (LA) dilatation is an important prognostic marker. 1 In patients with chronic HF, LA enlargement has been associated with severity of symptoms, reduced exercise capacity, poorer prognosis, 2 and it is a predictor of atrial fibrillation. 3 Thus, measurement of LA size has become an essential component of multiparametric evaluation of patients with HF. 2 Besides LA dimensions and remodeling, LA function also plays an important role. Being interposed between pulmonary circulation and LV, LA buffers pressure and flow oscillations during cardiac cycle and acts as elastic reservoir, passive conduit, and active booster, thus optimizing LV filling. 4 Conversely, impaired LA function can induce further hemodynamic stress on the pulmonary circulation in HF. 5 LA function has been traditionally assessed by measuring changes of LA volume during cardiac cycle. 4, 6 By measuring LA phasic volume changes, Melenovsky et al 7 recently demonstrated that impaired LA total ejection fraction (LAtEF) was associated with mortality in HF with preserved EF (HFpEF).
Two-dimensional speckle tracking echocardiography (STE) allows accurate quantification of LV systolic shortening; more recently, STE has proved useful in measuring LA distension, thus allowing assessment of LA reservoir function, by measuring peak LA longitudinal strain (PALS) during LV systole, with good feasibility and reproducibility. 8 In the general population, PALS has shown greater prognostic power than conventional parameters of LA function. 9 Recently, LA reservoir function assessed by PALS has emerged as a measure of LA dysfunction also in patients with HFpEF, 10 in whom it can predict outcome independent of potential clinical confounders. 11, 12 However, no studies have investigated the impact of PALS on prognosis in patients with HFrEF. Aim of the present study was to evaluate the prognostic role of LA reservoir function, assessed both as LA volume phasic changes and STE, in a consecutive series of patients with HFrEF, and to evaluate whether LA reservoir function could add prognostic information with respect to other conventional clinical and echocardiographic prognosticators in HF.
METHODS
The data that support the findings of this study are available from the corresponding author on reasonable request.
From January 2013 to December 2016, patients with chronic HFrEF, >18 years old, referred to the Echo-Lab of our HF clinic for a comprehensive echocardiographic evaluation, were evaluated. Patient data were entered in a prospective database, including demographics, clinical, medications, and echocardiographic variables. Inclusion criteria were (1) systolic dysfunction (LVEF, ≤40%), (2) stable sinus rhythm, (3) no/moderate-to-severe aortic stenosis or degenerative mitral regurgitation, (4) no planned revascularization procedures, and (5) optimized medical therapy since 3 months. Patients with HF because of a reversible cause, hospital readmission for worsening HF in the last month, hypertrophic cardiomyopathy, untreated thyroid disease, pericardial disease, amyloidosis, prosthetic valve, recent myocardial infarction (≤6 months), and poor technical quality of echocardiograms were excluded, as were those with <1-year life expectancy because of comorbidities. The hemoglobin value closest to enrollment (<3 months) was used to define anemia (hemoglobin concentration, <13.0 g/dL in men and <12.0 g/dL in women). 13 Estimated glomerular filtration rate was calculated using the serum creatinine value closest to clinical evaluation, by MDRD study (Modification of Diet in Renal Disease) equation; chronic kidney disease was defined by estimated glomerular filtration rate <60 mL/min per 1.73 m 2 during the last 3 months. 14 Venous blood samples for brain natriuretic peptide (BNP) assessment were drawn on the day of index echocardiography. Chilled EDTA tubes were centrifuged immediately at 4000g (48C) for 15 minutes. Plasma samples were processed by immunofluorescence assay. For BNP, the lower assay detection limit was 1 pg/mL.
The EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure) score 15 (a risk score for patients with HFrEF, including age, sex, systolic blood pressure, estimated glomerular filtration rate, diabetes mellitus, prior HF hospitalization, hemoglobin, prior myocardial infarction/coronary artery bypass graft, body mass index, and heart rate) was calculated.
CLINICAL PERSPECTIVE
In the present study, the prognostic impact of left atrial (LA) reservoir function as assessed by measuring peak atrial longitudinal strain (PALS) by speckle tracking echocardiography (STE) was compared with that derived by conventional LA function indices (LA total ejection fraction [LAtEF] , by phasic volume changes, and LA functional index [LAFI] ), in patients with heart failure (HF) with reduced ejection fraction (HFrEF). All LA function parameters significantly predicted outcome at univariable analysis during a median follow-up of 30 months, with PALS showing the highest predictive accuracy (area under the curve, 0.75; sensitivity, 73%; specificity, 70%). Impaired PALS was associated with greater left ventricular (LV) and LA volumes, worse left ventricular ejection fraction (LVEF), LV global longitudinal strain (LVGLS), right ventricular (RV) systolic function, and more severe diastolic dysfunction. After multivariable adjustment (including LA volume and LVGLS), PALS, but not LAtEF or LAFI, remained significantly associated with outcome (P=0.030). PALS provided incremental predictive value (by continuous net reclassification improvement, P=0.0009) over a base model, including age, sex, LA volume, ejection fraction (EF), E/E′ ratio, and LVGLS. Therefore, assessment of LA reservoir function by measuring PALS might allow powerful prognostication in patients with HFrEF.
The study protocol was approved by the local ethics committee, and a written informed consent was obtained from all participants.
Standard 2-Dimensional Echocardiography
All patients underwent standard transthoracic echocardiography using a Vivid 7 or Vivid S6 ultrasound system (GE Vingmed Healthcare) equipped with a 4S 3.5 mHz transducer. Exams were stored on a Echo-PAC v113 workstation for offline analysis (GE Healthcare, Horten, Norway). LV end-diastolic and end-systolic volumes, EF, and mass were measured as recommended. 6 Cardiac chamber volumes and mass measures were indexed to body surface area.
Pulsed-wave peak early (E) and atrial (A) velocities of mitral inflow, their ratio (E/A), and early mitral inflow deceleration time were measured as recommended. 16 Pulsed-wave tissue doppler imaging was used to detect lateral and septal mitral annulus early diastolic velocities (E′), which were averaged. The ratio of early transmitral flow velocity to the tissue doppler imaging mitral annular averaged E′ velocity (E/E′) was considered an index of mean LV filling pressure 16 and used to grade diastolic dysfunction combined with other parameters (E/A ratio of transmitral flow, LA volume index [LAVI] , and peak tricuspid regurgitation jet velocity), as suggested. 16 The velocity time integral of the LV outflow tract was averaged over 3 beats by planimetry of the spectrum of aortic pulsed-wave Doppler profile.
Right ventricular (RV) function was assessed by measuring tricuspid annular plane systolic excursion. 17, 18 Systolic pulmonary arterial pressure was estimated by combining the tricuspid regurgitation jet velocity with an estimate of right atrial pressure based on diameter and collapsibility of the inferior vena cava. 19 Severity of mitral regurgitation (grades I-IV) was determined by measuring the effective regurgitant orifice area or vena contracta width, as suggested.
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Longitudinal Deformation Analysis
LV longitudinal deformation was assessed by measuring global longitudinal strain (GLS) as the average longitudinal strain across 18 segments obtained from apical 4-, 2-, and 3-chamber views using a semiautomatic algorithm (Echo-PAC v113). 21 Because LV contraction results in ventricular shortening in systole, GLS yields negative values. In case GLS could only be assessed in 2 of 3 views, GLS was calculated as the average of these 2 views. If GLS could only be assessed in 1 view, the patient was excluded.
Assessment of Atrial Mechanics
Using the modified Simpson rule, LA volume at LV end systole (LAV max ), and LA volume at end diastole (LAV min ) were measured from apical 4-and 2-chamber views. LAtEF-an index of reservoir function-was calculated as ([LAV max −LAV min ]/ LAV max ×100). 4 LAV max was indexed to body surface area to obtain LAVI mL/m 2 -an index of LA remodeling. 4, 6 LA functional index (LAFI)-a marker of atrial function, which incorporates analogues of cardiac output, atrial reservoir function, and LA size-was calculated as LAFI=LAtEF×velocity time integral of the LV outflow tract/LAVI. 22 For STE analysis of LA function, 2-dimensional grayscale images were acquired in standard apical 4-and 2-chamber views at a frame rate of ≥60 frames per second. The recordings were processed using an acoustic tracking dedicated software (Echo-Pac), which allowed offline semiautomated analysis of speckle-based strain. To measure LA reservoir function, we used the QRS onset of the ECG as a reference point. 8 After selecting the cardiac cycle, the LA endocardial surface was manually traced by a point-and-click approach in both apical 2-and 4-chamber views, generating a region of interest that was manually adjusted to fill the thickness of LA myocardium. The software then divides the LA myocardium into 6 segments for each view (12 segments total). PALS values measured in each LA segment from the 2-and 4-chambers views, corresponding to the end of LA reservoir phase, were then averaged to obtain global PALS (Figure 1 ). Because the LA expands during ventricular systole, peak LA strain is a positive value, with smaller numeric values of PALS denoting worse LA reservoir function. If >2 segments could not be tracked or there were missing views, non-Digital Imaging and Communications in Medicine images, or significant foreshortening of the cavity, the patient was excluded.
Follow-Up
Patients were regularly followed-up at our outpatient HF clinic by both clinical visits and telephone calls, made on a regular basis. For the purpose of this study, the primary end point was the composite of death from any cause or HF hospitalization, whichever first. All-cause mortality was recorded by chart review, telephone contact, and electronic files of death certificates. After enrollment in the study, information on HF hospitalization was obtained from a systematic review of all hospital admissions performed by an independent reviewer unaware of clinical and echocardiographic data. For patients without events, the date of last contact was used for survival analysis.
Statistical Analysis
Data for continuous variables are presented as mean±SD or as median with interquartile range in case of skewed distribution. Categorical variables are expressed as percentage. Baseline clinical and echocardiographic data were analyzed according to PALS tertiles, using a trend test for categorical variables and 1-way ANOVA with Bonferroni correction or its nonparametric equivalents (Kruskal-Wallis test) for continuous variables. B-type natriuretic peptide was positively skewed and analyzed as log(concentration) in a continuous fashion. The relationships between PALS, GLS, and LAVI were examined by Pearson correlation analysis. Multiple linear regression analysis was further performed to explore the independent impact of LA volume and GLS on PALS, as dependent variable, after controlling for age, sex, heart rate, tricuspid annular plane systolic excursion, systolic pulmonary arterial pressure, and E/E′ ratio.
We first examined the performance of each LA function parameter to predict the composite end point using timedependent receiver operating characteristic (ROC) curve analysis. 23 The optimal prognostic cutoff value (Youden method) of each LA function parameter was derived from the area under the curve assessed at 3-year follow-up.
After performing standard Cox proportional hazards models for initial exploratory analyses to estimate coefficients and hazard ratios associated with each potential clinical and echocardiographic predictors, we used fractional polynomials regression to model nonlinear risk relations with continuous variables where appropriate. Several multivariable-adjusted models were constructed: model 1 included the EMPHASIS-HF risk score, 15 New York Heart Association class, log-transformed BNP, implanted cardioverter defibrillator at baseline, and cardiac resynchronization therapy implant during follow-up (as time-dependent variable); model 2 included model 1+LAVI, end-diastolic volume index, EF, E/E′ ratio, and mitral regurgitation grade severity; and model 3 included model 2+GLS. We compared models using the Akaike information criterion, Bayes information criterion 24 (likelihood measures in which lower values indicate better fit and in which a penalty is paid for increasing the number of variables in the model), and Harrell C index. Comparison of C index was made as proposed by Kang et al. 25 We tested interactions between predictor variables and PALS (Table I in the Data Supplement): significant interactions were included in the final model when they improved the model fit based on Akaike information criterion. Each multivariable-adjusted Cox model was tested in 1000 bootstrap samples to assess the potential effect of PALS in randomly regenerated data. Event rates (per 100 patients per year) were calculated. The proportional hazards assumption for the final model was verified by inspecting the log-log plot of survival and using Schoenfeld residuals test. Similar analyses were performed for LAtEF and LAFI. Calibration of the final model was also tested. 24 Survival curves for cumulative events as a function over time were obtained using the Kaplan-Meier method and compared using log-rank statistic.
Net reclassification improvement, and integrated discrimination index were estimated to evaluate the incremental value of adding PALS to a risk model, including age, sex, LAVI, EF, E/E′ ratio, and GLS, using a set time of 3 years comparable with the average follow-up time. We assessed reclassification of evens risk using continuous net reclassification improvement because it does not require prior definition of strata risk, thus considering the change in the estimation prediction as a continuous variable. 25, 26 In sensitivity analyses, we repeated Cox regression model after excluding patients who had severe mitral regurgitation.
Interobserver and intraobserver reproducibility of PALS was assessed in 22 randomly selected patients, with calculation of mean difference and 95% limits of agreement by Bland-Altman method and Lin concordance correlation coefficient. Analyses were performed with STATA 13 (StataCorp LP), R statistic (version 3.4.2), and SAS University Edition (SAS Institute, Cary, NC). A 2-tailed P value of <0.05 was considered statistically significant.
RESULTS
Of a total 655 patients with HFrEF, 201 did not met inclusion criteria, leading to 454 patients with HFrEF initially screened. Forty-three patients were excluded because of echocardiographic window not suitable for STE analysis of LV (n=23) or LA (n=20); 6 patients were lost to follow-up. Thus, a final population of 405 patients met eligibility criteria and was used for the analysis. Table 1 shows baseline characteristics of study population according to tertiles of PALS: age averaged 65±12 years; median LVEF was 30% (interquartile range, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , 141 patients (35%) had New York Heart Association functional class >2, and in 156 patients (39%) ischemic heart disease was the underlying pathogenesis. Median (interquartile range) PALS, LAtEF, and LAFI were 15.5% (11.2%-20.6%), 37.5% (26.8%-47.8%), and 0.14 (0.08-0.23), respectively. (24) 25 (19) 19 (14) Ischemic (%) 154 (38) 41 (30) 55 (41) 60 (44) Idiopathic (%) 135 (33) 51 (38) 44 (33) 38 (28) Other/not specified (%) 39 (10) 11 (8) 10 (7) 18 (13) eGFR, mL Figure 2 . All LA function parameters showed an ROC curve area significantly >0.50. Global PALS showed the highest diagnostic accuracy in predicting the primary end point at 12, 24, and 36 months of follow-up compared with other LA function indices (Figure 2 ). A total of 201 patients (50%) had abnormal PALS (<15.5%) based on timedependent ROC analysis.
Reduced PALS (third tertile, ≤12.9%) was associated with older age, higher heart rate, advanced New York Heart Association class, higher prevalence of diabetes mellitus, Chronic obstructive pulmonary disease, and chronic kidney disease, greater BNP values, higher prevalence of loop diuretic use, and lower β-blocker use (Table 1) . Consequently, EMPHASIS-HF score was significantly greater in patients with impaired than in those with preserved PALS (Table 1) . With regard to echocardiographic variables, impaired PALS was associated with greater LV volumes, worse LV systolic function (both EF and GLS) and RV systolic function, more severe diastolic dysfunction, greater LAVI, and reduced values of other LA functional indices (P=0.0001 for all; Table 2 ). There was an inverse correlation between PALS and both LAVI (r=−0.41; P<0.0001) and GLS (r=−0.69; P<0.0001; Table II in the Data Supplement): the higher the LAVI, or the more impaired the LV global longitudinal strain (LVGLS), the lower the PALS. Both LAVI and GLS resulted independently associated with PALS in multiple linear regression analysis after adjustment for age, sex, heart rate, systolic pulmonary arterial pressure, and E/E′ ratio (β, −0.16; P<0.0001 for LAVI; β, −0.55; P<0.0001 for LVGLS; adjusted R-squared of the model, 0.55). Figure 3 shows PALS values plotted against tertiles of LVGLS and LAVI: for any given value of LAVI, PALS progressively reduced as LVGLS became impaired. Also, for any given value of LVGLS, PALS decreased with increasing values of LAVI.
Prognostic Value of LA Indices
The test of nonlinearity of multivariable fractional polynomials regression (comparing best-fitting fractional polynomial type-2 against linear model) showed nonsignificant differences between linear and polynomial transformed forms of covariates (Table III in ment). Therefore, PALS was used in its linear form. These results were replicated for other atrial functional indices.
Both LAtEF and LAFI were associated with an increased risk for the primary composite end point in unadjusted analysis (Table 3 ), but they were no longer significant when adjusted for other clinical and echocardiographic covariates of interest in multivariable models (Table 3) .
PALS was also significantly associated with an increased risk of the composite end point in unadjusted analysis (Table 3) : patients in the third tertile of PALS (≤ 12.9%) showed much higher event rate (29.8 per 100 patients per year [95% CI, 23.7-37.7]) than patients in the lower tertile ( Figure 4B; P<0.0001) . Importantly, the association of PALS with adverse outcome remained significant after multivariable adjustment for clinical (EMPHASIS-HF score, New York Heart Association class, log[BNP], implanted cardioverter defibrillator at baseline, and cardiac resynchronization therapy implant during followup) and echocardiographic predictors, including LAVI, end-diastolic volume index, EF, GLS, E/E′ ratio, and mitral regurgitation severity ( Figure 4A shows survival curves by Kaplan-Meier analysis for patients stratified by PALS tertiles: patients with abnormal PALS showed significantly worse survival than patients with preserved PALS.
In sensitivity analysis, we repeated Cox regression after excluding patients with severe mitral regurgitation: the main findings of the study were confirmed (Table IV in the Data Supplement).
The strength of PALS as contributor to risk prediction translated into augmented predictive ability of risk model for the primary end point, as evidenced by a significant improvement in reclassification index (net reclassification improvement, 0.449%; 95% CIs, 0.113-0.643; P=0.0009) and absolute integrated discrimination index (0.032%; 95% CIs, 0.003-0.080; P=0.007), above and beyond a base model, including age, sex, LAVI, EF-estimated LV filling pressures, and GLS (Table V in the Data Supplement). 
DISCUSSION
The major findings of the present study, in a large, contemporary cohort of patients with HFrEF, are (1) reduced (worse) PALS was significantly related to more advanced HF and more impaired indices of LV systolic and diastolic function; (2) PALS was significantly better at predicting outcome than measurements of LA reservoir function based on phasic volume changes; (3) impaired PALS strongly predicted adverse outcome, independent of other clinical and echocardiographic predictors of prognosis; and (4) PALS added further prognostic information with respect to LA volume, estimated LV filling pressures, and LVGLS. The role of increased LA volume as a predictor of adverse outcome in patients with HFrEF has been consistently observed in individual studies 27, 28 and meta-analysis. 29 Also, our group has confirmed the independent prognostic role of the indexed LA volume as an important component of the Echo-HF score-an echocardiographic risk score for mortality in HFrEF. 30, 31 However, although increased LA volume may reflect the chronic effect of increased LV filling pressures, LA may also enlarge in the presence of normal filling pressures (eg, healthy athletes, subjects with lone atrial arrhythmias); hence, measures of LA dimensions may not always provide a reliable estimate of LA pressure or function.
In spite of the prognostic relevance of LA remodeling, whether atrial function predicts outcomes in patients with HFrEF is poorly investigated. Beside Doppler recording of the late component of transmitral flow, LA function is typically quantified using volumetric assessment of LA reservoir, conduit, and booster pump functions obtained by echocardiography measures of LA volumes at end systole, end diastole, and immediately before atrial contraction. From these volumes, Carluccio et al; Left Atrial Strain and Prognosis in Heart Failure total, passive, and active LA EFs can be calculated. 1, 4 However, evaluation of changes of LA volume during the different phases of the cardiac cycle is particularly time consuming; furthermore, the application of a simple geometric model to a nonsymmetrical chamber may affect estimation of LA volume.
Comparison With Previous Studies
By cardiac magnetic resonance imaging of outpatients referred with suspected HF, Pellicori et al 32 showed that patients with confirmed HF had more impaired LA emptying function compared with those without HF and that by multivariable Cox model increasing LA empting function, but not LVEF, was independently associated with survival in patients with HF. However, cardiac magnetic resonance imaging use is limited by availability, costs, and operator skills. In contrast, echocardiography is widely available and easily performed, and in the clinical setting, it is probably the method of choice to measure LA function. 1 Through an echocardiography estimate of LA work (LA kinetic energy [LAKE]), Mazzone et al 33 assessed LA function in patients with either HFpEF (n=63) or HFrEF (n=180). During 4.1 year followup, the risk of cardiovascular death or HF hospitalization was 4× higher in patients with abnormally high LAKE than in those with normal LAKE in the overall HF cohort. However, in that study, patients with Doppler evidence of either pseudonormal or restrictive LV filling pattern were excluded because increased LV filling pressures could hamper measurement of LAKE, and this reduces the ability to extrapolate and extend the use of LAKE to many patients with HFrEF. More recently, by measuring LA function through echocardiographic assessment of LA phasic volume changes (LAtEF), Melenovsky et al 7 showed that LA dysfunction was evident in both HFrEF and HFpEF compared with controls, but it was significantly associated with mortality only in the HFpEF group. However, in that retrospective study, LA strain was not assessed, and HFrEF cohort was relatively small. 7 Recently, with development and widespread use of myocardial deformation analysis techniques, such as STE, quantification of LA 2-dimensional strain has gained interest to assess LA function. 8 Several studies have documented the prognostic role of PALS in different clinical settings, including general population, 9 myocardial infarction, 34 aortic stenosis, 35 HFpEF, 10,11 and pulmonary hypertension. 36 Importantly, PALS emerged as a superior method for LA function quantification compared with measures based on phasic volume changes, as LAtEF. 9 To our knowledge, no study yet has specifically addressed the relationship between LA reservoir function, assessed by STE, and prognosis in patients with HFrEF. In the present study, performed in a contemporary cohort of patients with HFrEF, we assessed LA reservoir function by both conventional phasic volume changes (LAtEF) and by global PALS. We found that quantification of LA function by deformation analysis techniques (PALS) was superior to methods based on phasic volumes changes (LAtEF) in predicting outcome (greater area under the curve at follow-up) and that, contrary to LAtEF, the predictive value of PALS was retained after multivariable adjustment for known clinical and echocardiographic predictors, also showing incremental prognostic information with respect to LA volume, estimated filling pressures, and GLS.
According to the concept of a constant volume pump throughout the cardiac cycle, during LV systole, the descending mitral and tricuspid annuli stretch both atria so that atrial and ventricular volumes reciprocate, whereas total cardiac volume remains nearly constant. 37 Therefore, the magnitude of LA expansion would be affected by the degree of LV longitudinal contraction. As reported by Appleton and Kovács, 37 these kinematic relations can mostly be appreciated by cardiac magnetic resonance imaging cine-loops of normal hearts. Indeed, previous studies in patients with normal EF 10, 12, 34 reported that PALS and GLS were significantly correlated, thus negating an independent prognostic role of peak LA strain. In our study, we also observed a significant correlation between PALS and GLS, supporting that the more advanced is LV longitudinal dysfunction, the more impaired is LA reservoir function. However, LA relaxation phase may also be impaired by myocyte loss and atrial fibrosis, both of which likely present in patients with HFrEF, 2 potentially limiting atrial stretching (distension) independently of the degree LV longitudinal contraction. This finding might explain why, in our study of patients with HFrEF with different degree of cardiac remodeling, the relationship between PALS and LVGLS did not ablate the independent prognostic value of LA strain. To this regard, our findings agree with that of Freed et al 11 who showed in patients with HFpEF that LA reservoir strain remained independently associated with the composite outcome of cardiovascular hospitalization or death, even after adjustment for GLS.
We observed a significant association of LA strain with estimated LV filling pressure (E/E′ ratio), pulmonary artery systolic pressure, and RV systolic function (by tricuspid annular plane systolic excursion). One negative effect of LA dysfunction is the backward transmission of LA pressure to pulmonary capillaries, leading to pulmonary congestion and pulmonary hypertension. Pulmonary hypertension leads to RV afterload, promoting progression of RV failure. 5 These observations might explain why LA dysfunction is strongly associated with development of dyspnea and decompensation in patients with HF.
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Limitations
This is a single-center experience. STE requires user experience and high-quality images, and it is not currently recommended for routine LA assessment.Low signal-to-noise ratio, thin atrial wall, and presence of the appendage and pulmonary veins make LA strain imaging currently more difficult than LV strain, and there is no standardization of LA strain acquisition. However, feasibility and reproducibility of PALS in our study was good, with excellent agreement. Cutoff values for abnormal LA strain are not well defined, and reference limits of LA strain derived from large populations are lacking; in the present study, the cutoff of PALS (15.5%) was obtained using time-dependent ROC analysis relative to our population. Finally, we assessed RV function by tricuspid annular plane systolic excursion; other more sensitive methodologies are now available, 38 which can refine the association between LA strain and RV dysfunction.
In conclusion, in patients with HFrEF, LA reservoir strain is the speckle tracking measure of LA function strongly associated with estimated elevated filling pressure, impaired LV and RV systolic function, and independently associated with increased risk of the composite end point of HF hospitalization or all-cause death. Furthermore, it provides incremental prognostic information over LA volume, LV filling pressures, and GLS.
